Clinical Trial Update: Nanoparticles in Nasal Mucosa

View source ↗

Summary

A completed clinical trial from University Hospital Ostrava studying nanoparticles applied to nasal mucosa for chronic rhinosinusitis conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Snippet

Sponsor: University Hospital Ostrava | Conditions: Chronic Hypertrophic Rhinosinusitis, Chronic Polypous Rhinosinusitis | Status: COMPLETED